• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Percent of advisory committee members participating in meetings in the month who were granted waivers

FY 2011 Target: Less than 12.3%

Dictionary: When FDA determines that an advisory committee member has a financial conflict of interest, the agency may grant a waiver that allows the member to participate in an advisory committee meeting if certain criteria and policies are met. In general, FDA may grant a waiver if the requirements set forth by 18 U.S.C. 208 are met. FDA searches for experts who have the necessary expertise without conflicts of interest; yet, in some cases, the top authorities in specialized scientific fields may have a conflict of interest. When FDA grants a waiver, the financial interests associated with the waiver are posted on FDA’s website along with the reasons for granting the waiver.

Information is current as of June 30, 2014.

Fiscal Year - 2011

Skip graphic and jump to text data

FY 2011 Target: Less than 12.3%

TimeTargetPercent Granted Waivers
Oct 201012.30
Nov 201012.31
Dec 201012.31
Jan 201112.30
Feb 201112.30
Mar 201112.31
Apr 201112.30
May 201112.30
Jun 201112.31
Jul 201112.34
Aug 201112.31
Sep 201112.30

FY 2011 Overall: 1%

Total number of advisory committee members participating in meetings in the month who were granted waivers

Fiscal Year - 2011
Skip graphic and jump to text data.

TimeTargetWaivers Granted
Oct 2010N/A0
Nov 2010N/A2
Dec 2010N/A1
Jan 2011N/A0
Feb 2011N/A0
Mar 2011N/A2
Apr 2011N/A0
May 2011N/A0
Jun 2011N/A1
Jul 2011N/A4
Aug 2011N/A1
Sep 2011N/A0

FY 2011 Total: 11

Total number of advisory committee members participating in meetings in the month

Fiscal Year - 2011
Skip graphic and jump to text data.

TimeTargetCommittee Members
Oct 2010N/A87
Nov 2010N/A197
Dec 2010N/A154
Jan 2011N/A88
Feb 2011N/A53
Mar 2011N/A150
Apr 2011N/A96
May 2011N/A157
Jun 2011N/A71
Jul 2011N/A108
Aug 2011N/A75
Sep 2011N/A128

FY 2011 Total: 1,364

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.